Emyria Ltd has released a press release.
Empax Centre Selected As Key Site In Global PTSD Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- March 2024 Quarterly Activities Report and Appendix 4C
- Emyria Receives Bids of $2.3M to Expand Clinical Services
- Emyria opens Empax Centre to target care gaps in resistant PTSD
- Emyria Opens Empax Centre to Advance Mental Health Care
- Emyria Expands Specialist AP Team - First Female for MDMA-AT
Later from Emyria
- Emyria, UWA Secure $499K Grant for MDMA Analogue Program
- June 2024 Quarterly Activities Report and Appendix 4C
- Appendix 4E & Annual Report for the Year Ended 30 June 2024
- Emyria Shares Interim Success in PTSD Treatment Program
- Emyria Gains Ethics Endorsement for Psilocybin Program
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria